Delivery Order SPE2DB25D7060-SPE2DB25FXSGV

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,940.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, with a period of performance through July 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,081.59, is for the supply of fluticasone-salmeterol 45-21 12GM, a respiratory medication. The contract is a firm fixed-price delivery order with a completion date of March 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a $15,759.93 delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for fluticasone-salmeterol 230-21 12GM, a specialty medication used for the treatment of respiratory conditions. The contract has a ceiling value of $15,759.93 and runs through June 12, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.06 delivery order is for the supply of Fluticasone-Salmeterol 45-21 12GM, a medication used in the treatment of respiratory conditions. The contract has an ultimate completion date of October 17, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a $4,360.69 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a medication used to treat respiratory conditions. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a $7,991.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of fluticasone-salmeterol 115-21 inhalation medication in 12 gram quantities. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication. The award has a ceiling value of $2,340.03 and an ultimate completion date of August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 115-21 12GM, a respiratory medication. The contract has a firm fixed price of $2,675.76 and a completion date of July 23, 2024. The contract is not set aside for any specific business designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,641.16, is for the supply of Fluticasone-Salmeterol 115-21 12GM, a medication used for respiratory health. This contract is not designated as a set-aside and allows for open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,996.08, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a medication used for respiratory conditions. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB25D7060
    Indefinite Delivery Contract
  • SPE2DB25D7060-SPE2DB25FXSGV
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,759.87, is for the supply of fluticasone-salmeterol 45-21 12GM, a medication used to treat respiratory conditions. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/2/25, 9:52 AM